The current PE ratio of BLFS can't be determined, as the TTM EPS of -$1.42 is negative. The most recent PE ratio recorded for Biolife Solutions was 604.57 in September 2021.
Over the last six years, the average PE ratio of Biolife Solutions has been 429.74. In the past six years, BLFS's PE ratio was at its highest in the Jun 2021 quarter at 1,483.67, with a price of $44.51 and an EPS of $0.03. The Mar 2020 quarter recorded the bottom point at 5.86, with a price of $9.5 and an EPS of $1.62.
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | 569.86 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| CE Celanese Corp | 8.61 | $17.18B |
| ENTA Enanta Pharmaceuticals Inc | N/A | $256.91M |
| BLFS Biolife Solutions Inc | N/A | $1.01B |
The current price to earnings ratio of BLFS can't be calculated, as its EPS of -$1.42 is negative.
Over the last 5 years, the average price to earnings ratio for BLFS stock is 464.9.
In the last six years, the Jun 2021 quarter recorded the highest quarterly PE ratio at 1,483.67.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.